Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation

Generalized forms of invasive meningococcal desease (IMD) are very dangerous because they have a high mortality rate.The aim of the work was to assess the cost-effectiveness of meningococcal vaccination of infants with the 4-valent MenACWY-D conjugate vaccine in the Russian Federation.Material and m...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Rudakova, A. A. Vilnits, S. M. Kharit, Yu. V. Lobzin
Format:	Article
Language:	Russian
Published:	Journal Infectology 2021-12-01
Series:	Журнал инфектологии
Subjects:	meningococcal disease 4-valent vaccine infants cost-effectiveness
Online Access:	https://journal.niidi.ru/jofin/article/view/1277
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The socioeconomic burden of meningococcal infection in the Russian Federation
by: Yu. V. Lobzin, et al.
Published: (2024-12-01)

Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
by: Adriana Efron, et al.
Published: (2023-12-01)

Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China
by: Haonan Zhang, et al.
Published: (2024-12-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Cost effectiveness analysis of universal varicella vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-10-01)

An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
by: Asmaa Alrobai, et al.
Published: (2021-12-01)

Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany
by: Sebastian Gruhn, et al.
Published: (2025-03-01)

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age
by: V. V. Romanenko, et al.
Published: (2023-11-01)

Cost-effectiveness of vaccination against HPV of adolescent girls in the regions of Russian Federation
by: A. V. Rudakova, et al.
Published: (2024-12-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2023-01-01)

Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea
by: N. N. Kostyukova, et al.
Published: (2024-07-01)

Evaluation of the Cost-Effectiveness of Vaccination of Children with 5-valent Vaccine against Rotavirus Infection in the Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018-01-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
by: L. S. Namazova-Baranova, et al.
Published: (2023-01-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Assessment of reduction of rotavirus infection burden in case of vaccination with a pentavalent vaccine in Russian Federation
by: A. V. Rudakova, et al.
Published: (2014-09-01)

Cost-effectiveness of gender neutral vaccination of adolescents against human papillomavirus infection in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2024-01-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial
by: Federico Martinon-Torres, et al.
Published: (2025-07-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Evaluation of the potential economic effects in the increased vaccination against meningococcal infection based on real epidemiological data
by: S. V. Svetlichnaya, et al.
Published: (2023-08-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines
by: S. M. Kharit, et al.
Published: (2017-06-01)

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
by: Georgina Tzanakaki, et al.
Published: (2024-12-01)

Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)
by: N. V. Skripchenko, et al.
Published: (2016-07-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018-01-01)